US 12,133,874 B2
Application of breast milk-derived Lactobacillus reuteri in regulating maternal and infant immune function
Jin Sun, Wuxi (CN); Shuangqi Li, Changsha (CN); Ce Qi, Wuxi (CN); and Mengfan Ding, Wuxi (CN)
Assigned to Fine (Hunan) Biotechnology Co., Ltd., Changsha (CN); Jin Sun, Wuxi (CN); and Fine (Guangzhou Biotechnology Co., Ltd., Guangzhou (CN)
Filed by Fine (Hunan) Biotechnology Co., Ltd., Changsha (CN); Jin Sun, Wuxi (CN); and Fine (Guangzhou) Biotechnology Co., Ltd., Guangzhou (CN)
Filed on Jan. 19, 2022, as Appl. No. 17/578,537.
Application 17/578,537 is a continuation of application No. PCT/CN2020/080353, filed on Mar. 20, 2020.
Claims priority of application No. 202010076261.7 (CN), filed on Jan. 23, 2020.
Prior Publication US 2022/0133820 A1, May 5, 2022
Int. Cl. A61K 39/02 (2006.01); A01N 63/00 (2020.01); A23L 33/135 (2016.01); A61K 35/747 (2015.01); A61P 37/04 (2006.01)
CPC A61K 35/747 (2013.01) [A23L 33/135 (2016.08); A61P 37/04 (2018.01)] 16 Claims
 
1. A method of enhancing immunity, establishing an intestinal barrier, and/or strengthening the intestinal barrier, which comprises
administering to a subject in need thereof Lactobacillus reuteri Fn041 or a composition comprising L. reuteri Fn041,
wherein administering the L. reuteri Fn041 enhances immunity, establishes an intestinal barrier, and/or enhances an intestinal barrier in the subject,
wherein the subject is an infant, pregnant woman, or lactating woman, and
wherein the L. reuteri Fn041 has a preservation number GDMCC No. 60546.